Thus, these data suggested that SHMT2 may be applied as a valuable biomarker for poor prognosis and might have an important role in the progression and lymph node metastasis of colorectal cancer. The gene discussed is SHMT2; the disease is metastatic malignant neoplasm in the lymph nodes.